Literature DB >> 31367989

Chronic Fistula Post Laparoscopic Nissen Sleeve Gastrectomy: Conversion to Roux-en-Y Gastric Bypass.

Imed Ben Amor1, Tarek Debs1, Niccolo' Petrucciani2, Giorgio Dalmonte1, Maria Marcantonio1, Patrick Chevallier3, Radwan Kassir4, Jean Gugenheim1.   

Abstract

BACKGROUND: Sleeve gastrectomy (SG) is the most frequently performed bariatric intervention worldwide, and obese patients have a higher risk of developing reflux symptoms compared with the general population [1, 2]. One of the controversies of SG is to perform it in patients with gastroesophageal reflux disease (GERD). Some studies have shown that SG may exacerbate GERD symptoms or even increase the risk of "de novo" postoperative GERD [3, 4]. Laparoscopic Nissen fundoplication is an effective treatment for patients with severe GERD. In order to avoid the Roux-en-Y gastric bypass (RYGB), some authors combined the SG with the Nissen fundoplication in morbid obese patients with GERD [5]. As after SG, postoperative gastric fistula may occur after Nissen SG. Persistent fistula after Nissen SG may be treated by conversion to RYGB.
METHODS: We present the case of a 35-year-old woman with long-standing morbid obesity, who presented to our institution seeking management options for her postoperative fistula. In August 2018, she underwent a laparoscopic Nissen SG in another institution. Her initial weight was 107 kg, height 172 cm, and body mass index (BMI) 36.27 kg/m2. At the 7th postoperative day, she complained of severe abdominal pain and fever. A computed tomography (CT) scan was performed showing a massive supra-mesocolic pneumoperitoneum. An explorative laparoscopy was performed with evidence of a generalized peritonitis without identification of the orifice of the leak. Peritoneal lavage of the abdominal cavity was done and the patient was transferred to our institution. An upper gastrointestinal endoscopy was performed with evidence of a fistula on the gastric longitudinal staple line (8 mm in diameter), and a stenosis of about 15 mm on the distal gastric tube. A double pig-tail was placed. After 14 days, the patient underwent a gastric pneumatic dilatation of the stenosis placed at the antro-fundic region, without complications. Three months later, the fistula was persistent; therefore, after a careful nutritional and psychological evaluation and discussion with the patient, we decided to perform a conversion to a RYGB. The valve of the Nissen fundoplication was identified and divided using a stapler. The orifice of the fistula was identified. Resection of this valve, including the orifice of the fistula and the gastric tube, was done using a blue-load stapler ECHELON FLEX™ GST (Ethicon Endo-Surgery, USA) while creating the new gastric pouch. Then, we performed a Roux-en-Y gastric bypass with a 150-cm alimentary limb and a 50-cm biliary limb. The Petersen and the mesenteric defects were closed.
RESULTS: The blood loss was less than 100 cc and the operative time was 240 min. The postoperative period was smooth and uneventful; the patient was started on liquid diet on the second postoperative day and discharged at day 8. At 1 month postoperatively, the patient has lost 16 kg and the %EWL was 36.53%, %TWL 14.95% with a BMI of 30.84 kg/m2. At 6 months postoperatively, the patient lost 24 kg, with a BMI at 26 kg/m2. She does not complain of GERD, no vomiting, no abdominal pain, and no diarrhea.
CONCLUSIONS: In cases of fistulas after Nissen SG, the surgery becomes more tedious and difficult. Conversion to RYGB seems a feasible and effective option to treat chronic fistula after Nissen SG.

Entities:  

Keywords:  Nissen sleeve; Revisional bariatric surgery; Roux-en-Y gastric bypass; Surgical technique

Mesh:

Year:  2019        PMID: 31367989     DOI: 10.1007/s11695-019-04080-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  5 in total

1.  Effect of sleeve gastrectomy on gastroesophageal reflux.

Authors:  Jan S Burgerhart; Charlotte A I Schotborgh; Erik J Schoon; Johannes F Smulders; Paul C van de Meeberg; Peter D Siersema; André J P M Smout
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

2.  Trends of bariatric surgery in France during the last 10 years: analysis of 267,466 procedures from 2005-2014.

Authors:  Tarek Debs; Niccolo Petrucciani; Radwan Kassir; Antonio Iannelli; Imed Ben Amor; Jean Gugenheim
Journal:  Surg Obes Relat Dis       Date:  2016-05-11       Impact factor: 4.734

3.  Laparoscopic Nissen fundoplication with gastric plication as a potential treatment of morbidly obese patients with GERD, first experience and results.

Authors:  Wei-Jei Lee; Ming-Lun Han; Kong-Han Ser; Ju-Juin Tsou; Jung-Chien Chen; Chia-Hsien Lin
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

4.  A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years.

Authors:  Jacques Himpens; Giovanni Dapri; Guy Bernard Cadière
Journal:  Obes Surg       Date:  2006-11       Impact factor: 4.129

5.  Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass.

Authors:  Mariel A Mejía-Rivas; Alejandro Herrera-López; Jorge Hernández-Calleros; Miguel F Herrera; Miguel A Valdovinos
Journal:  Obes Surg       Date:  2008-05-30       Impact factor: 4.129

  5 in total
  3 in total

1.  Why Choosing the Roux-en-Y Gastric Bypass in a Morbid Obese with a History of a Failed Nissen Fundoplication Is Not a Dogma.

Authors:  Antonio Iannelli; Sébastien Frey; Niccolo Petrucciani
Journal:  Obes Surg       Date:  2020-11       Impact factor: 4.129

Review 2.  Is It Safe to Combine a Fundoplication to Sleeve Gastrectomy? Review of Literature.

Authors:  Sergio Carandina; Viola Zulian; Anamaria Nedelcu; Marc Danan; Ramon Vilallonga; David Nocca; Marius Nedelcu
Journal:  Medicina (Kaunas)       Date:  2021-04-18       Impact factor: 2.430

3.  The Nissen-Sleeve (N-Sleeve): Results of a Cohort Study.

Authors:  Imed Ben Amor; Vincent Casanova; Geoffroy Vanbiervliet; Jean Marc Bereder; Richard Habitan; Radwan Kassir; Jean Gugenheim
Journal:  Obes Surg       Date:  2020-09       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.